Lifestyle, family history, and risk of idiopathic parkinson disease: A large danish case-control study

American Journal of Epidemiology

Volumn 181, Issue 10, 2015, Pages 808-816

  Kenborg, Line ^a   Lassen, Christina F ^b   Ritz, Beate ^c   Andersen, Klaus K ^a   Christensen, Jane ^a   Schernhammer, Eva S ^d,e   Hansen, Johnni ^a   Wermuth, Lene ^f   Rod, Naja H ^g   Olsen, Jørgen H ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

alcohol drinking; caffeine; case control study; lifestyle; Parkinson disease; smoking

Indexed keywords

CAFFEINE;

ALCOHOL; DRINKING; DRUG USER; HEALTH RISK; LIFESTYLE; REGRESSION ANALYSIS; SMOKING;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BEER; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; DRINKING BEHAVIOR; FAMILY HISTORY; FEMALE; HUMAN; IDIOPATHIC DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK ASSESSMENT; RISK FACTOR; SMOKING; TOBACCO CONSUMPTION; WINE; ADVERSE EFFECTS; ODDS RATIO; RISK; STATISTICAL MODEL; VERY ELDERLY;

DENMARK;

NICOTIANA TABACUM;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CAFFEINE; CASE-CONTROL STUDIES; DENMARK; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; RISK; SMOKING;

EID: 84929590409     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu332     Document Type: Article

References (39)

1. Dorn HF. Tobacco consumption and mortality from cancer and other diseases. Public Health Rep. 1959;74(7):581-593.
2. Chen H, Huang X, Guo X, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74(11): 878-884.
3. Hernán MA, Zhang SM, Rueda-deCastro AM, et al. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol. 2001;50(6):780-786.
4. Ritz B, Ascherio A, Checkoway H, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007; 64(7):990-997.
5. Thacker EL, O'Reilly EJ, Weisskopf MG, et al. Temporal relationship between cigarette smoking and risk of Parkinson disease. Neurology. 2007;68(10):764-768.
6. Ascherio A, Zhang SM, Hernán MA, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol. 2001;50(1):56-63.
7. Ascherio A, Weisskopf MG, O'Reilly EJ, et al. Coffee consumption, gender, and Parkinson's disease mortality in the Cancer Prevention Study II cohort: the modifying effects of estrogen. Am J Epidemiol. 2004;160(10):977-984.
8. Hu G, Bidel S, Jousilahti P, et al. Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord. 2007;22(15): 2242-2248.
9. Liu R, Guo X, Park Y, et al. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol. 2012;175(11):1200-1207.
10. Saäksjärvi K, Knekt P, Rissanen H, et al. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr. 2008;62(7):908-915.
11. Grandinetti A, Morens DM, Reed D, et al. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol. 1994;139(12): 1129-1138.
12. Hernán MA, Chen H, Schwarzschild MA, et al. Alcohol consumption and the incidence of Parkinson's disease. Ann Neurol. 2003;54(2):170-175.
13. Palacios N, Gao X, O'Reilly E, et al. Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women. Mov Disord. 2012;27(8):980-987.
14. Zhang D, Jiang H, Xie J. Alcohol intake and risk of Parkinson's disease: a meta-analysis of observational studies. Mov Disord. 2014;29(6):819-822.
15. Istvan J, Matarazzo JD. Tobacco, alcohol, and caffeine use: a review of their interrelationships. Psychol Bull. 1984;95(2): 301-326.
16. Brown CR, Jacob P 3rd, Wilson M, et al. Changes in rate and pattern of caffeine metabolism after cigarette abstinence. Clin Pharmacol Ther. 1988;43(5):488-491.
17. Davis TJ, de Fiebre CM. Alcohol's actions on neuronal nicotinic acetylcholine receptors. Alcohol Res Health. 2006; 29(3):179-185.
18. Elbaz A, Manubens-Bertran JM, Baldereschi M, et al. Parkinson's disease, smoking, and family history. EUROPARKINSON Study Group. J Neurol. 2000;247(10): 793-798.
19. Thacker EL, Ascherio A. Familial aggregation of Parkinson's disease: a meta-analysis. Mov Disord. 2008;23(8):1174-1183.
20. Rybicki BA, Johnson CC, Peterson EL, et al. A family history of Parkinson's disease and its effect on other PD risk factors. Neuroepidemiology. 1999;18(5):270-278.
21. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181-184.
22. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33-39.
23. Rugbjerg K, Ritz B, Korbo L, et al. Risk of Parkinson's disease after hospital contact for head injury: population based case-control study. BMJ. 2008;337:a2494.
24. Rothman KJ. Measuring interactions. In: Epidemiology: An Introduction. 2nd ed. New York, NY: Oxford University Press; 2012:198-210.
25. Powers KM, Kay DM, Factor SA, et al. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord. 2008;23(1):88-95.
26. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology. 2000;55(9): 1350-1358.
27. Checkoway H, Powers K, Smith-Weller T, et al. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol. 2002; 155(8):732-738.
28. Fall PA, Fredrikson M, Axelson O, et al. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord. 1999;14(1):28-37.
29. Hellenbrand W, Seidler A, Boeing H, et al. Diet and Parkinson's disease. I: a possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology. 1996;47(3):636-643.
30. Nicoletti A, Pugliese P, Nicoletti G, et al. Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study. Mov Disord. 2010;25(14):2387-2394.
31. Paganini-Hill A. Risk factors for Parkinson's disease: the Leisure World Cohort Study. Neuroepidemiology. 2001;20(2): 118-124.
32. Menza M. The personality associated with Parkinson's disease. Curr Psychiatry Rep. 2000;2(5):421-426.
33. Ross GW, Petrovitch H. Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease. Drugs Aging. 2001;18(11):797-806.
34. Brust JC. Ethanol and cognition: indirect effects, neurotoxicity and neuroprotection: a review. Int J Environ Res Public Health. 2010;7(4):1540-1557.
35. Feduccia AA, Chatterjee S, Bartlett SE. Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions. Front Mol Neurosci. 2012; 5:83.
36. Hancock DB, Martin ER, Vance JM, et al. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Neurogenetics. 2008;9(4): 249-262.
37. Levecque C, Elbaz A, Clavel J, et al. Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet. 2003;12(1):79-86.
38. Wermuth L, Lassen CF, Himmerslev L, et al. Validation of hospital register-based diagnosis of Parkinson's disease. Dan Med J. 2012;59(3):A4391.
39. Elbaz A, McDonnell SK, Maraganore DM, et al. Validity of family history data on PD: evidence for a family information bias. Neurology. 2003;61(1):11-17.